US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 41.62% Potential Upside in the Diagnostics Sector

For investors with a keen interest in the healthcare sector, Veracyte, Inc. (VCYT) offers a compelling opportunity with a noteworthy potential upside of 41.62%. Specializing in..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 65% Potential Upside in the Booming Biotech Sector

Investors with an eye on the healthcare sector may find Immunovant, Inc. (NASDAQ: IMVT) an intriguing opportunity. This clinical-stage biotechnology firm, based in New York and..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 71.91% Potential Upside

UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry, as it continues to pique investor interest with its..

SS Innovations International (SSII) Stock Analysis: Revenue Soars with Innovative Surgical Solutions

SS Innovations International Inc. (SSII), trading on the Indian market, is carving its niche in the healthcare sector with a market capitalization of approximately $980.64 million...

Enovis Corporation (ENOV) Stock Analysis: Exploring a 100.72% Upside Potential in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, has been drawing attention with its noteworthy potential upside of 100.72%. As a medical technology..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Deep Dive into its 79% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering company in the gene-editing landscape, presents a compelling investment case with a potential upside of 79.09%, according to the..

Metsera, Inc. (MTSR)

⚠️ No article content returned.

..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Unpacking the 37.86% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical company headquartered in Boulder, Colorado, has captured investor attention with a compelling potential upside of 37.86%. This promising figure,..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Potential 167.64% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is a biopharmaceutical endeavor that stands at the forefront of developing treatments for rare and ultra-rare genetic diseases. This California-based company,..

GeneDx Holdings Corp. (WGS) Investor Outlook: A 117% Potential Upside Sparks Interest

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its remarkable..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 51% Upside

Bausch Health Companies Inc. (NYSE: BHC), a diversified healthcare entity, has drawn attention from investors with its impressive potential upside of 51.26%, as indicated by the..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a 154% Potential Upside in Biotech

Biohaven Ltd. (BHVN), a prominent player in the biotechnology sector, has been capturing investor attention due to its promising pipeline of therapeutics and an impressive potential..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech with 14% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotechnology sector, not only for its innovative pipeline but also for its promising potential upside. With a..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 98% Upside Potential in the Biotech Sector

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering entity in the biotechnology sector, has emerged as a promising contender in the healthcare industry. With a market capitalization..

Warby Parker Inc. (WRBY) Stock Analysis: Strong Buy Ratings Signal Potential 20% Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, has captured the attention of investors with its innovative business model and robust growth..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Analyzing a Promising 117% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the healthcare sector, particularly within the drug manufacturing space, for its robust pipeline and substantial growth potential. With..

NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 63.41% Upside with Promising Biotech Innovations

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is making waves in the biotechnology sector with its innovative approach to treating cardiometabolic diseases. With a market capitalization of..

Twist Bioscience Corporation (TWST) Stock Analysis: Insights into a 12% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST), a dynamic player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its promising..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating Market Challenges with 23.7% Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is making waves with its commitment to developing innovative treatments for rare diseases. Despite..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Biotech with 57% Upside Potential and Rapid Revenue Growth

ImmunityBio, Inc. (NASDAQ: IBRX) has captured investor attention with its remarkable positioning in the biotechnology sector. The San Diego-based company focuses on innovative immunotherapies aimed at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds